Summary
M2 EQUITYBITES-April 25, 2011-Idera Pharmaceuticals announces delay in Phase 2 clinical study of IMO-2125 in HCV patients
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Imo-2125 in Hcv Patients
Drug company Idera Pharmaceuticals Inc (Nasdaq:ID...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Pudding Makers Show Different Taste in Art | It Could Still Be You | Serran s Early Sending Off Means a Point Is a Decent Result Coca-Cola Championship 16th-Mi... | hughton stumped coca-cola league two | Millington-Tipton Area Weekly Varsity Football Schedule | Senior Center May Be Moving ; the Location On Hyatt Street Is Bigger and has Much Needed Parking Space. | Neighbors Headlines | Tecumseh Downs Tipp, Stays Perfect
